Leukemia Home > Chronic Myeloid Leukemia and Tasigna

If you have been diagnosed with chronic myeloid leukemia (CML), Tasigna® (nilotinib) may help slow down the progression of your cancer. This prescription chemotherapy drug works to treat this specific type of leukemia by reducing the activity of a certain type of protein in the body that the cancer cells need to grow and multiply. It is approved for use in adults age 18 and older.
CML is a slowly progressing leukemia in which bone marrow stem cells (the early cells that form blood cells) develop into many abnormal granulocytes (a type of white blood cell). Some of these cells never become mature white blood cells (also called blasts). Over time, the granulocytes and blasts crowd out the red blood cells and platelets in the bone marrow.
(Click Tasigna Uses for a closer look at how Tasigna can help treat chronic myeloid leukemia. This article also lists other possible uses and talks about whether the medicine is safe for use in older adults.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.